Compare NAMM & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAMM | GNLX |
|---|---|---|
| Founded | 2024 | 2001 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.5M | 113.6M |
| IPO Year | N/A | 2022 |
| Metric | NAMM | GNLX |
|---|---|---|
| Price | $1.60 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | ★ 465.8K | 183.4K |
| Earning Date | 04-02-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,000.00 |
| Revenue This Year | $76.84 | N/A |
| Revenue Next Year | $85.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.91 | $2.29 |
| 52 Week High | $27.78 | $8.54 |
| Indicator | NAMM | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 30.42 | 65.60 |
| Support Level | $1.29 | $3.03 |
| Resistance Level | $1.80 | $3.70 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 6.25 | 77.70 |
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.